You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AIO

Showing 1 - 25 of 158
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Patients With Advanced Solid Tumor (Excluding NSCLC, SCLC, and Mesothelioma) With Results From a Multi-gene Next-generation

Not yet recruiting
  • Patients With Advanced Solid Tumor (Excluding NSCLC, SCLC, and Mesothelioma) With Results From a Multi-gene Next-generation Sequencing (NGS) Panel (>30 Genes)
  • Minimal documentation
  • Extended documentation
  • Mannheim, Baden-Württemberg, Germany
  • +1 more
Jan 18, 2023

Acute Lymphocytic Leukemia Trial in Beijing, Tianjin (LCAR-AIO Cells)

Recruiting
  • Acute Lymphocytic Leukemia
  • LCAR-AIO Cells
  • Beijing, Beijing, China
  • +1 more
May 31, 2022

B-cell Lymphoma Recurrent, B-cell Lymphoma Refractory Trial in Beijing, Tianjin (LCAR-AIO cells product)

Recruiting
  • B-cell Lymphoma Recurrent
  • B-cell Lymphoma Refractory
  • LCAR-AIO cells product
  • Beijing, Beijing, China
  • +1 more
Apr 1, 2022

Chemo-refractory Colorectal Carcinoma Trial in Hamburg, Ulm (Maximum tolerated dose, MTD: D,L-methadone HCl (Methasan® 10

Recruiting
  • Chemo-refractory Colorectal Carcinoma
  • Maximum tolerated dose, MTD: D,L-methadone hydrochloride (Methasan® 10 mg/ml)
  • Hamburg, Germany
  • +1 more
Apr 21, 2022

Esophagogastric Adenocarcinoma Trial (Pembrolizumab, Trastuzumab, FLOT)

Not yet recruiting
  • Esophagogastric Adenocarcinoma
  • (no location specified)
Aug 17, 2022

Esophagus Adenocarcinoma Trial in Frankfurt (Durvalumab, FLOT, mFOLFOX-6)

Not yet recruiting
  • Esophagus Adenocarcinoma
  • Frankfurt, Germany
    Institute of Clinical Cancer Research, University Cancer Center
Jan 26, 2023

Resectable Pancreatic Cancer, Ductal Adenocarcinoma of the Pancreas Trial in Ulm (perioperative nab-paclitaxel/gemcitabine,

Completed
  • Resectable Pancreatic Cancer
  • Ductal Adenocarcinoma of the Pancreas
  • perioperative nab-paclitaxel/gemcitabine
  • adjuvant nab-paclitaxel/gemcitabine
  • Ulm, Germany
    University of Ulm, Dept. of Internal Medicine I
Nov 21, 2022

Metastatic Colorectal Cancer Trial in Berlin (Panitumumab 20 milligram/ML, Bevacizumab, Trifluridine/Tipiracil Hydrochloride)

Recruiting
  • Metastatic Colorectal Cancer
  • Panitumumab 20 milligram/ML
  • +2 more
  • Berlin, Germany
    Charité - Universitätsmedizin Berlin
Jul 20, 2022

Metastatic Pancreatic Ductal Adenocarcinoma Trial in Friedrichshafen (OFF, FOLFIRI Protocol)

Terminated
  • Metastatic Pancreatic Ductal Adenocarcinoma
  • OFF
  • FOLFIRI Protocol
  • Friedrichshafen, Germany
    Praxis für Innere Medizin
Dec 21, 2021

Adenocarcinoma of the Lung Trial in Großhansdorf (nintedanib-nivolumab combination therapy)

Active, not recruiting
  • Adenocarcinoma of the Lung
  • nintedanib-nivolumab combination therapy
  • Großhansdorf, Germany
    LungenClinic Grosshansdorf
Dec 14, 2021

Patients With Solid Tumors and Malignant Lymphoma

Completed
  • Anemia, Iron Deficiency
  • +2 more
  • non-interventional retrospective epidemiological observational study
  • Kaiserslautern, Germany
    Studienzentrum Prof. Dr. med. Hartmut Link, Facharzt für Innere
Feb 14, 2022

Quality Assurance of Secondary Immunodeficiencies in CLL/MM

Completed
Has Results
  • Secondary Immunodeficiencies (SID)
  • non-interventional retrospective epidemiological observational study
  • Kaiserslautern, Germany
    Privatärztliche Praxis; Innere Medizin, Hämatologie, Internistis
Nov 10, 2021

Rectal Cancer Trial in Mannheim (mFOLFOX (neoadjuvant), XELOX (neoadjuvant), mFOLFOX (adjuvant))

Recruiting
  • Rectal Cancer
  • mFOLFOX (neoadjuvant)
  • +6 more
  • Mannheim, Germany
    Unversity Hospital Mannheim
Aug 12, 2022

Incidental Gallbladder Carcinoma, Biliary Tract Cancer Trial in Frankfurt (Gemcitabine, Cisplatin, Oncologically radical

Recruiting
  • Incidental Gallbladder Carcinoma
  • Biliary Tract Cancer
  • Frankfurt, Germany
    Krankenhaus Nordwest gGmbH
Sep 7, 2022

Gastric Cancer Trial in Frankfurt am Main (5-Fluorouracil, Leucovorin, Oxaliplatin)

Recruiting
  • Gastric Cancer
  • Frankfurt am Main, Germany
    Krankenhaus Nordwest
Feb 21, 2022

Venous Thromboembolism, Cancer Trial in Aachen (Rivaroxaban, low-molecular heparine)

Terminated
  • Venous Thromboembolism
  • Cancer
  • Aachen, Germany
    Uniklinik
Apr 28, 2021

Head and Neck Squamous Cell Carcinoma Trial in France, Germany, Spain (Cisplatin, 5-Fluorouracile, Docetaxel)

Completed
  • Head and Neck Squamous Cell Carcinoma
  • Avignon, France
  • +16 more
Aug 22, 2022

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Germany (5-Fluorouracil, Leucovorin, Oxaliplatin)

Recruiting
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • Aachen, Germany
  • +14 more
Sep 7, 2022

Colon Cancer Stage II Trial in Dresden (Capecitabine)

Recruiting
  • Colon Cancer Stage II
  • Dresden, Sachsen, Germany
    Universitaetsklinikum Carl Gustav Carus, Medizinische Klinik
Aug 5, 2020

The Canadian/US Integrative Oncology Study

Active, not recruiting
  • Breast Neoplasms
  • +3 more
    • Scottsdale, Arizona
    • +11 more
    Oct 21, 2022

    Colorectal Cancer, Colon Cancer, BRAF V600E Trial (Binimetinib)

    Not yet recruiting
    • Colorectal Cancer
    • +4 more
    • (no location specified)
    Aug 18, 2022

    Stomach Cancer, Gastroesophageal Junction Cancer Trial in Frankfurt (FLOT alone, FLOT + Herceptin/Pertuzumab)

    Completed
    • Stomach Cancer
    • Gastroesophageal Junction Cancer
    • FLOT alone
    • FLOT + Herceptin/Pertuzumab
    • Frankfurt, Germany
      Institute for Clinical Cancer Research Krankenhaus Nordwest
    Aug 10, 2020

    Rectal Cancer Trial in Frankfurt (drug, radiation, procedure)

    Recruiting
    • Rectal Cancer
    • Kineret 100 MG in 0.67 ML Prefilled Syringe
    • +3 more
    • Frankfurt, Germany
      University Hospital Goethe University Frankfurt
    Aug 23, 2022

    Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck, Carcinoma, Squamous Cell of Head and Neck Trial in Essen

    Active, not recruiting
    • Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
    • Carcinoma, Squamous Cell of Head and Neck
    • Essen, Germany
      Essen University Hospital
    Nov 25, 2021

    To Investigate Airway Oxygen Concentrations During Rigid

    Not yet recruiting
    • Central Airway Obstruction
    • No intervention
    • Minneapolis, Minnesota
      University of Minnesota
    May 19, 2023